CCND2 and non-small cell lung carcinoma: To downregulate CCND1 and CCND2 expression and investigate the resulting effects on cell proliferation and cell cycle progression in the NSCLC cell lines, H1299 and SPCA-1, we used siRNAs targeting CCND1 and CCND2.